GERN
Geron Corp
Price:  
2.79 
USD
Volume:  
8,974,930.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-247.6%
Upside

As of 2025-02-14, the Relative Valuation of Geron Corp (GERN) is (4.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.79 USD, the upside of Geron Corp based on Relative Valuation is -247.6%.

The range of the Relative Valuation is (4.16) - (5.13) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.5x - 16.5x 14.5x
Forward P/E multiples 5.1x - 15.4x 10.2x
Fair Price (4.16) - (5.13) (4.12)
Upside -249.1% - -283.7% -247.6%
2.79 USD
Stock Price
(4.12) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -8.80
2025-02-06 -8.80
2025-02-05 -9.07
2025-02-04 -8.74
2025-02-03 -8.56
2025-01-31 -8.62
2025-01-30 -8.65
2025-01-29 -8.68
2025-01-28 -9.01
2025-01-27 -8.89
2025-01-24 -9.04
2025-01-23 -9.07
2025-01-22 -8.98
2025-01-21 -8.89
2025-01-17 -8.68
2025-01-16 -8.77
2025-01-15 -9.04
2025-01-14 -8.83
2025-01-13 -8.95
2025-01-10 -9.52
2025-01-08 -10.28
2025-01-07 -10.22
2025-01-06 -10.31
2025-01-03 -10.73
2025-01-02 -10.82
2024-12-31 -10.64
2024-12-30 -10.22
2024-12-27 -10.07
2024-12-26 -9.92
2024-12-24 -10.04
2024-12-23 -10.04
2024-12-20 -10.49
2024-12-19 -11.00
2024-12-18 -11.33
2024-12-17 -11.81
2024-12-16 -11.45
2024-12-13 -11.60
2024-12-12 -11.78
2024-12-11 -11.96
2024-12-10 -11.99
2024-12-09 -11.96
2024-12-06 -11.81
2024-12-05 -11.96
2024-12-04 -12.02
2024-12-03 -11.87
2024-12-02 -12.14
2024-11-29 -12.38
2024-11-27 -12.53
2024-11-26 -12.20
2024-11-25 -12.32